RDs also can advocate for the safe and proper use of weight management medications in tandem with promoting the critical roles of healthful eating, lifestyle modifications, and medication adherence
May 2024 data from KFF showed that 6% of adults currently take any GLP-1 drug, with 12% saying they have taken the medications at any point in time
Utilization impact At the same time, if GLP-1s lead to sustained weight loss and better metabolic health, they could reduce the incidence of costly chronic conditions such as kidney disease or heart failure
"If approved, we are ready to offer a convenient, once-daily pill that can be scaled globally -- removing barriers and redefining how obesity is treated around the world," Kenneth Custer, Eli Lilly's executive vice president and president of Lilly Cardiometabolic Health, said in a statement